| Report Title | Price | Action |
|---|---|---|
| Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) (Cardiovascular) - Drugs in Development, 2021
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) (Cardiovascular) - Drugs in Development, 2021 Summary Giant Cell Arteriti...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021
DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021 Summary DNA Topoisomerase II (EC 5.99.1.3) - Drugs in Development, 2021 provides in ...
Published: Apr-2021 | No. of Pages: 130
|
$ 3000 | |
| Calpain 1 Catalytic Subunit (Calcium Activated Neutral Proteinase 1 or Calpain Mu Type or Calpain 1 Large Subunit or Cell Proliferation Inducing Gene 30 Protein or Micromolar Calpain or CAPN1 or EC 3.4.22.52) - Drugs in Development, 2021
Calpain 1 Catalytic Subunit (Calcium Activated Neutral Proteinase 1 or Calpain Mu Type or Calpain 1 Large Subunit or Cell Proliferation Inducing Gene ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Drugs in Development, 2021
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Drugs in Development, 2021 Summary Interleukin 2 (T Cell Growth Factor or Aldesleukin o...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Cerebral Edema (Central Nervous System) - Drugs in Development, 2021
Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 Summary Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Fetal Liver Kinase 2 or CD135 or FLT3 or EC 2.7.10.1) - Drugs in Development, 2021
Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Fetal Liver Kinase 2 ...
Published: Apr-2021 | No. of Pages: 140
|
$ 3000 | |
| Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) - Drugs in Development, 2021
Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) - Drugs in Development, 2021 Summary Calre...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Drugs in Development, 2021
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Drugs in Development, 2021 Summary Interleukin 10 (Cytokine Synthesis Inhibi...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021
Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021 Summary Corticobas...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 2021
Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 2021 Summary Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 140
|
$ 3000 | |
| Casein Kinase I Isoform Alpha (CKI Alpha or CK1 or CSNK1A1 or EC 2.7.11.1) - Drugs in Development, 2021
Casein Kinase I Isoform Alpha (CKI Alpha or CK1 or CSNK1A1 or EC 2.7.11.1) - Drugs in Development, 2021 Summary Casein Kinase I Isoform Alpha (CKI A...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 13 (IL13) - Drugs in Development, 2021
Interleukin 13 (IL13) - Drugs in Development, 2021 Summary Interleukin 13 (IL13) - Drugs in Development, 2021 provides in depth analysis on Interleu...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021
Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 Summary Motor Neuron Diseases (Central Nervous System) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing B Cell Receptor CD22 (B Lymphocyte Cell Adhesion Molecule or Sialic Acid Binding Ig Like Lectin 2 or T Cell Surface Antigen Leu 14 or CD22) - Drugs in Development, 2021
Cells Expressing B Cell Receptor CD22 (B Lymphocyte Cell Adhesion Molecule or Sialic Acid Binding Ig Like Lectin 2 or T Cell Surface Antigen Leu 14 or...
Published: Apr-2021 | No. of Pages: 140
|
$ 3000 | |
| CD27 Antigen (CD27L Receptor or T Cell Activation Antigen CD27 or Tumor Necrosis Factor Receptor Superfamily Member 7 or T14 or TNFRSF7 or CD27) - Drugs in Development, 2021
CD27 Antigen (CD27L Receptor or T Cell Activation Antigen CD27 or Tumor Necrosis Factor Receptor Superfamily Member 7 or T14 or TNFRSF7 or CD27) - Dru...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 15 (IL15) - Drugs in Development, 2021
Interleukin 15 (IL15) - Drugs in Development, 2021 Summary Interleukin 15 (IL15) - Drugs in Development, 2021 provides in depth analysis on Interleu...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021
Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Development, 2021 Summary Myalgia (Muscle Pain) (Central Nervous System) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA(A) Receptor or GABR) - Drugs in Development, 2021
Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA(A) Receptor or GABR) - Drugs in Development, 2021 Summary Gamma-Aminobutyric Acid Type A Recep...
Published: Apr-2021 | No. of Pages: 145
|
$ 3000 | |
| CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or Phagocytic Glycoprotein 1 or CD44) - Drugs in Development, 2021
CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteogly...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Tumor Necrosis Factor Ligand Superfamily Member 13B (B Lymphocyte Stimulator or Dendritic Cell Derived TNF Like Molecule or TNF And APOL Related Leukocyte Expressed Ligand 1 or CD257 or TNFSF13B) - Drugs in Development, 2021
Tumor Necrosis Factor Ligand Superfamily Member 13B (B Lymphocyte Stimulator or Dendritic Cell Derived TNF Like Molecule or TNF And APOL Related Leuko...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 |